Frazier Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$403 Hold
1
﹤0.01% 587
2026
Q1
$303 Hold
1
﹤0.01% 795
2025
Q4
$361 Hold
1
﹤0.01% 619
2025
Q3
$373 Sell
1
-4
-80% -$1.24K ﹤0.01% 605
2025
Q2
$2K Hold
5
﹤0.01% 519
2025
Q1
$2.23K Hold
5
﹤0.01% 493
2024
Q4
$1.88K Hold
5
﹤0.01% 512
2024
Q3
$2.65K Sell
5
-7
-58% -$3.74K ﹤0.01% 661
2024
Q2
$6.54K Buy
12
+1
+9% +$529 0.01% 541
2024
Q1
$5.74K Buy
11
+5
+83% +$2.49K ﹤0.01% 567
2023
Q4
$2.85K Buy
+6
New +$2.77K ﹤0.01% 627

Other funds holding ELV

Frazier Financial Advisors's ELV Position: Q2 2026 in Review

Frazier Financial Advisors held its Elevance Health (ELV) position steady in Q2 2026 at 1 share worth $403. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Frazier Financial Advisors first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.54K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Frazier Financial Advisors held 1 share of Elevance Health worth $403 as of Q2 2026.
  • Frazier Financial Advisors left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q2 2026, its #587 holding.
  • Frazier Financial Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Frazier Financial Advisors's Elevance Health position peaked at $6.54K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.